Shopping Cart
- Remove All
 
Your shopping cart is currently empty
Leucettinib-21 (LCTB-21) (compound 4) serves as a selective and potent inhibitor of DYRK1A, exhibiting IC50 values of 2.4, 6.7, 12, 33, and 5 nM for DYRK1A, DYRK1B, CLK1, CLK2, and CLK4, respectively. This compound is applicable for the study of Down syndrome and Alzheimer's disease [1].

| Pack Size | Price | Availability | Quantity | 
|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 
| Description | Leucettinib-21 (LCTB-21) (compound 4) serves as a selective and potent inhibitor of DYRK1A, exhibiting IC50 values of 2.4, 6.7, 12, 33, and 5 nM for DYRK1A, DYRK1B, CLK1, CLK2, and CLK4, respectively. This compound is applicable for the study of Down syndrome and Alzheimer's disease [1].  | 
| Synonyms | LCTB-21 | 
| Molecular Weight | 358.46 | 
| Formula | C18H22N4O2S | 
| Cas No. | 2732859-75-3 | 
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | 

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.